Invacare Corp. (IVC) Shares Down 2.2%
Invacare Corp. (NYSE:IVC) shares traded down 2.2% during mid-day trading on Monday . The stock traded as low as $12.14 and last traded at $12.17, with a volume of 146,752 shares traded. The stock had previously closed at $12.45.
Separately, Zacks Investment Research cut Invacare Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, August 2nd.
The stock’s market cap is $389.63 million. The stock has a 50-day moving average of $12.40 and a 200 day moving average of $12.42.
Invacare Corp. (NYSE:IVC) last issued its earnings results on Thursday, July 28th. The company reported ($0.33) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.24) by $0.09. The business earned $275 million during the quarter, compared to analyst estimates of $270.10 million. During the same period last year, the company earned ($0.23) EPS. The company’s revenue for the quarter was down 3.9% on a year-over-year basis. Equities analysts anticipate that Invacare Corp. will post ($0.95) EPS for the current fiscal year.
An institutional investor recently raised its position in Invacare Corp. stock. Ancora Advisors LLC increased its position in Invacare Corp. (NYSE:IVC) by 1.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 72,542 shares of the company’s stock after buying an additional 742 shares during the period. Ancora Advisors LLC owned approximately 0.22% of Invacare Corp. worth $1,216,000 as of its most recent filing with the SEC.
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.